• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫达非尼:临床前、临床及上市后监测——滥用倾向问题综述

Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.

作者信息

Myrick Hugh, Malcolm Robert, Taylor Brent, LaRowe Steven

机构信息

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

出版信息

Ann Clin Psychiatry. 2004 Apr-Jun;16(2):101-9. doi: 10.1080/10401230490453743.

DOI:10.1080/10401230490453743
PMID:15328903
Abstract

Modafinil is an agent that is frequently used in the treatment of narcolepsy. More recently it has been used in the treatment of a variety of psychiatric, neurological, and medical illnesses. Due to its ability to improve wakefulness, modafinil has been viewed as a stimulant. Based on the potential for modafinil to become widely used in a variety of syndromes and settings, evidence from preclinical in vitro and in vivo studies, human laboratory studies, and post-marketing experiences examining the potential abuse liability of modafinil were reviewed. Initial evidence suggests that modafinil has limited potential for large-scale abuse.

摘要

莫达非尼是一种常用于治疗发作性睡病的药物。最近,它已被用于治疗多种精神、神经和医学疾病。由于其能够改善清醒状态,莫达非尼被视为一种兴奋剂。基于莫达非尼可能在多种综合征和环境中广泛使用的可能性,我们回顾了临床前体外和体内研究、人体实验室研究以及上市后有关莫达非尼潜在滥用可能性的经验证据。初步证据表明,莫达非尼大规模滥用的可能性有限。

相似文献

1
Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.莫达非尼:临床前、临床及上市后监测——滥用倾向问题综述
Ann Clin Psychiatry. 2004 Apr-Jun;16(2):101-9. doi: 10.1080/10401230490453743.
2
Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.莫达非尼及其他治疗发作性睡病相关日间过度嗜睡药物的滥用可能性评估。
Clin Neuropharmacol. 2000 May-Jun;23(3):149-56. doi: 10.1097/00002826-200005000-00004.
3
[Modafinil: pharmacology and therapeutic perspectives].[莫达非尼:药理学与治疗前景]
Rev Neurol (Paris). 2003 Jan;159(1):122-5.
4
Modafinil in the treatment of excessive daytime sleepiness.莫达非尼治疗日间过度嗜睡
Cleve Clin J Med. 2007 Aug;74(8):561-6, 568-71. doi: 10.3949/ccjm.74.8.561.
5
Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants.莫达非尼对曾接受精神兴奋剂治疗的患者改善日间觉醒的疗效及安全性。
Sleep Med. 2003 Jan;4(1):43-9. doi: 10.1016/s1389-9457(02)00240-x.
6
Modafinil: a second look. Confirmed efficacy in narcolepsy.莫达非尼:再审视。对发作性睡病疗效确凿。
Prescrire Int. 1999 Feb;8(39):5-7.
7
[Modafinil (Midiodal): wakefulness stimulant in narcoleptic patients].
Presse Med. 2000 Jun 10;29(20):1131-2.
8
Modafinil approved for narcolepsy.莫达非尼被批准用于发作性睡病。
Am J Health Syst Pharm. 1999 Feb 15;56(4):304. doi: 10.1093/ajhp/56.4.304.
9
[Modafinil in psychiatric disorders: the promising state reconsidered].[莫达非尼在精神疾病中的应用:对其前景的重新审视]
Tijdschr Psychiatr. 2010;52(11):763-73.
10
What is modafinil?莫达非尼是什么?
Harv Ment Health Lett. 2005 Jan;21(7):8.

引用本文的文献

1
Prevalence, incidence, and medications of narcolepsy in Japan: a descriptive observational study using a health insurance claims database.日本发作性睡病的患病率、发病率及药物治疗情况:一项使用健康保险理赔数据库的描述性观察研究
Sleep Biol Rhythms. 2022 Aug 30;20(4):585-594. doi: 10.1007/s41105-022-00406-4. eCollection 2022 Oct.
2
Discovery and Development of Monoamine Transporter Ligands.单胺转运体配体的发现和开发。
Adv Neurobiol. 2023;30:101-129. doi: 10.1007/978-3-031-21054-9_4.
3
A Novel and Selective Dopamine Transporter Inhibitor, -MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions.
一种新型、选择性的多巴胺转运体抑制剂 -MK-26,可促进海马突触可塑性,并恢复与努力相关的动机功能障碍。
Biomolecules. 2022 Jun 24;12(7):881. doi: 10.3390/biom12070881.
4
A rare case of modafinil dependence presenting as sleep disorder.一例以睡眠障碍为表现的莫达非尼依赖罕见病例。
Ind Psychiatry J. 2021 Oct;30(Suppl 1):S354-S355. doi: 10.4103/0972-6748.328856. Epub 2021 Oct 22.
5
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.皮替立定,一种无精神刺激作用的觉醒促进剂:与安非他命、莫达非尼和索里昂的临床前比较。
Pharmacol Res Perspect. 2021 Oct;9(5):e00855. doi: 10.1002/prp2.855.
6
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.抗抑郁药维拉佐酮是一种 5-羟色胺转运体的变构抑制剂。
Nat Commun. 2021 Aug 20;12(1):5063. doi: 10.1038/s41467-021-25363-3.
7
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?精神兴奋剂使用障碍,一个未实现的治疗目标:莫达非尼能缩小差距吗?
Front Neurosci. 2021 May 26;15:656475. doi: 10.3389/fnins.2021.656475. eCollection 2021.
8
Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors.使用自由活动大鼠的 EEG 对中枢作用药物进行药理学分类:识别新型非典型多巴胺摄取抑制剂的旧工具。
Neuropharmacology. 2019 Dec 15;161:107446. doi: 10.1016/j.neuropharm.2018.11.034. Epub 2018 Nov 24.
9
The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors.莫达非尼和苯丙胺单次注射对小鼠内侧前额叶皮质表观遗传和功能标记物的影响:多巴胺受体的潜在作用。
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:222-234. doi: 10.1016/j.pnpbp.2018.07.019. Epub 2018 Jul 26.
10
Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex.反复使用甲基苯丙胺和莫达非尼会导致小鼠内侧前额叶皮层产生不同的认知效应和特定的组蛋白乙酰化及 DNA 甲基化谱。
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:1-11. doi: 10.1016/j.pnpbp.2017.12.009. Epub 2017 Dec 13.